focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (1.235%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.15
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues update on Agronomics (ANIC)

10 Mar 2023 07:15

RNS Number : 4617S
Agronomics Limited
10 March 2023
 

London, UK, 10 March 2023

 

Edison issues update on Agronomics (ANIC)

Agronomics invests in cellular agriculture companies. Since mid-2022 it has placed increasing emphasis on companies using precision fermentation technology or providing contract precision fermentation services, as these appear to have greater near-term commercial potential than cultivated meat and seafood. Agronomics' NAV has risen almost 100% since the inception of the current strategy in April 2019, and looks set to increase further as the company's portfolio holdings receive regulatory approval for their products and/or begin generating income. ANIC is the only UK-listed vehicle targeting cellular agriculture, thus offering investors a rare opportunity to gain exposure to this exciting and rapidly expanding, but difficult to access, sector. The company is trading at a rare discount to NAV, providing investors with a chance to gain exposure at a particularly attractive price.

 

ANIC's share price is trading at an uncharacteristic discount to cum-income NAV, for reasons that, arguably, have little do with the company's performance. In our view, this situation provides investors with an opportunity that is unlikely to persist for too long, due to the increasing appetite for sustainable investments and the scarcity of alternative investment options in the cellular agriculture sector. The potential of eventual valuation uplifts to ANIC's portfolio holdings should also support the share price and diminish the discount over time.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Joanne Collins +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAFDNEEXDEFA
Date   Source Headline
10th Apr 20137:00 amRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSNet Asset Value calculation to 31st March 2013
28th Mar 20137:00 amRNSHalf Yearly Report
8th Feb 20134:50 pmRNSDirector Dealing
8th Feb 20134:45 pmRNSReplacement - Director dealing
30th Jan 20139:55 amRNSDirector Dealing
25th Jan 20133:27 pmRNSNet Asset Value
1st Nov 20127:00 amRNSFinal Results
5th Oct 20122:07 pmRNSNet Asset Value
19th Jul 20123:44 pmRNSDirector/PDMR Shareholding
5th Jul 20121:09 pmRNSNet Asset Value
21st Jun 20127:00 amRNSDirector/PDMR Shareholding
18th Jun 20127:00 amRNSDirector/PDMR Shareholding
13th Jun 20127:00 amRNSDirectorate Change
30th May 201211:40 amRNSDirectorate Change
30th May 201211:14 amRNSHolding(s) in Company
11th Apr 20123:50 pmRNSNet Asset Value
30th Mar 20127:00 amRNSHalf Yearly Report
9th Jan 20123:42 pmRNSNet Asset Value
16th Dec 20114:24 pmRNSChange of Quarterly NAV valuation
20th Oct 20111:46 pmRNSDirector/PDMR Shareholding
14th Oct 20114:43 pmRNSDirector/PDMR Shareholding
14th Oct 201110:53 amRNSInvestment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.